GlassScriptPhysician profile
Gerard A Curtis
NPI 1447242805
$5,858.19
in general payments reported to CMS, 2019-2025
34 companies · $988 in 2025
The $988 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $450 · 2021: $929 · 2022: $636 · 2023: $770 · 2024: $1,074 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,747 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,746.89 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $825.64 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $590.38 | 2019-2024 | Xiaflex, Aveed, Edex |
| Janssen Biotech, INC. | $586.39 | 2019-2025 | Erleada |
| Teleflex LLC | $447.26 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $315.01 | 2023-2025 | Gemtesa |
| Coloplast Corp | $266.98 | 2019-2025 | Speedicath, Altis |
| Abbvie INC. | $207.25 | 2022-2025 | Botox |
| Astellas Pharma US INC | $197.48 | 2019-2022 | |
| Procept Biorobotics Corporation | $185.93 | 2024 | Aquabeam System |
| Olympus America INC. | $181.38 | 2020-2023 | Itind System |
| Boston Scientific Corporation | $179.82 | 2020-2025 | Axonics, Ams 700 |
| Tolmar, INC. | $174.76 | 2023-2025 | Eligard |
| Pfizer INC. | $170.68 | 2019 | |
| Therapeuticsmd, INC. | $156.97 | 2019 | |
| Allergan, INC. | $154.83 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $143.28 | 2025 | Adstiladrin |
| Medtronic, INC. | $138.76 | 2021 | |
| Medtronic USA, INC. | $138.17 | 2020 | |
| Axonics, INC. | $107.52 | 2023-2024 | Axonics |
| Valencia Technologies Corporation | $103.46 | 2024 | Ecoin Device Kit |
| Halozyme INC | $79.98 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $67.12 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $64.46 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $59.29 | 2019-2021 | |
| Clarus Therapeutics INC. | $51.39 | 2021 | |
| Urovant Sciences INC | $47.37 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $46.26 | 2025 | |
| Novartis Pharmaceuticals Corporation | $42.99 | 2019-2023 | |
| Blue Earth Diagnostics | $31.51 | 2019 | |
| Rochester Medical Corporation | $28.75 | 2019-2020 | |
| Endo USA, INC. | $23.62 | 2024 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $18.48 | 2022 | |
| Aytu Biopharma, INC. | $13.01 | 2019 | |
| Neotract INC. | $12.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.